PMV Pharmaceuticals, Inc. (PMVP)
PMVP Stock Price Chart
Explore PMV Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze PMVP price movements and trends.
PMVP Company Profile
Discover essential business fundamentals and corporate details for PMV Pharmaceuticals, Inc. (PMVP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Sept 2020
Employees
47.00
Website
https://www.pmvpharma.comCEO
David H. Mack
Description
PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.
PMVP Financial Timeline
Browse a chronological timeline of PMV Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.38.
Earnings released on 12 May 2026
EPS came in at -$0.34 surpassing the estimated -$0.41 by +17.07%.
Earnings released on 6 Mar 2026
EPS came in at -$0.34 surpassing the estimated -$0.40 by +15.00%.
Earnings released on 12 Nov 2025
EPS came in at -$0.40 matching the estimated -$0.40.
Earnings released on 7 Aug 2025
EPS came in at -$0.41 falling short of the estimated -$0.39 by -5.13%.
Earnings released on 9 May 2025
EPS came in at -$0.34 surpassing the estimated -$0.37 by +8.11%.
Earnings released on 3 Mar 2025
EPS came in at -$0.45 falling short of the estimated -$0.38 by -18.42%.
Earnings released on 7 Nov 2024
EPS came in at -$0.37 falling short of the estimated -$0.35 by -5.71%.
Earnings released on 8 Aug 2024
EPS came in at -$0.02 surpassing the estimated -$0.34 by +94.12%.
Earnings released on 9 May 2024
EPS came in at -$0.30 surpassing the estimated -$0.35 by +14.29%.
Earnings released on 29 Feb 2024
EPS came in at -$0.31 surpassing the estimated -$0.39 by +20.51%.
Earnings released on 9 Nov 2023
EPS came in at -$0.34 surpassing the estimated -$0.45 by +24.44%.
Earnings released on 9 Aug 2023
EPS came in at -$0.38 surpassing the estimated -$0.47 by +19.15%.
Earnings released on 10 May 2023
EPS came in at -$0.42 surpassing the estimated -$0.48 by +12.50%.
Earnings released on 1 Mar 2023
EPS came in at -$0.43 surpassing the estimated -$0.44 by +2.27%.
Earnings released on 8 Nov 2022
EPS came in at -$0.40 surpassing the estimated -$0.42 by +4.76%.
Earnings released on 9 Aug 2022
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%.
Earnings released on 10 May 2022
EPS came in at -$0.41 surpassing the estimated -$0.42 by +2.38%.
Earnings released on 1 Mar 2022
EPS came in at -$0.41 falling short of the estimated -$0.35 by -17.14%.
Earnings released on 12 Nov 2021
EPS came in at -$0.33 falling short of the estimated -$0.31 by -6.45%.
Earnings released on 13 Aug 2021
EPS came in at -$0.29 matching the estimated -$0.29.
PMVP Stock Performance
Access detailed PMVP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
